blog page Thalassemia

Exploring Thalassemia in Fetal Medicine

Thalassemia, a group of inherited blood disorders affecting hemoglobin production, poses significant challenges in fetal medicine. This article aims to delve into the intricacies of thalassemia from the perspective of fetal medicine, exploring its genetic basis, diagnostic approaches, and evolving treatment strategies.

Understanding Thalassemia

Thalassemia is characterized by abnormal hemoglobin synthesis, leading to anemia. Fetal medicine specialists often encounter cases where one or both parents are carriers of thalassemia gene mutations. The severity of the disorder varies, ranging from thalassemia trait carriers with minimal symptoms to thalassemia major, a potentially life-threatening condition.

Genetics and Inheritance

Thalassemia is primarily inherited in an autosomal recessive manner. Two types of globin chains constitute hemoglobin: alpha and beta. Thalassemia is categorized into alpha and beta thalassemias based on which chain is affected. Fetal medicine specialists play a crucial role in identifying carriers and assessing the risk of thalassemia in offspring through genetic counseling and prenatal testing.

Understanding Thalassemia Inheritance and Diagnosis:

Genetic Complexity:

  • Thalassemia, with its intricate genetic basis, involves mutations in the genes responsible for hemoglobin production.
  • Fetal medicine specialists delve into the nuanced genetic landscape, explaining to families the complexities of autosomal recessive inheritance and the specific mutations associated with alpha and beta thalassemias.

Alpha and Beta Thalassemia Distinctions:

  • Fetal medicine specialists delineate the differences between alpha and beta thalassemias, emphasizing the distinct genetic alterations in the alpha and beta globin genes.
  • This nuanced understanding guides diagnostic approaches and helps tailor interventions based on the specific type of thalassemia.

Carrier Screening Advancements:

  • Fetal medicine incorporates advancements in carrier screening techniques to identify individuals at risk.
  • Expanded carrier screening panels, including a wide range of genetic mutations, contribute to a more comprehensive assessment of thalassemia risk, allowing for targeted genetic counseling and informed decision-making for prospective parents.

Prenatal Genetic Testing Modalities:

  • Fetal medicine employs an array of prenatal genetic testing modalities to diagnose thalassemia during pregnancy.
  • Technologies such as next-generation sequencing and advanced imaging techniques enhance the accuracy of prenatal diagnosis, providing crucial information for families and guiding decisions regarding intervention and treatment.

Early Intervention Possibilities:

  • Identification of thalassemia carriers in the early stages of pregnancy allows for proactive and personalized management strategies.
  • Fetal medicine specialists collaborate with obstetricians to offer early interventions, potentially mitigating the impact of thalassemia on the developing fetus through advancements like in utero transfusions or cord blood transplantation.

Precision Medicine Approaches:

  • With the advent of precision medicine, fetal medicine specialists explore individualized treatment approaches based on the specific genetic mutations present.
  • This tailored approach aims to optimize outcomes by addressing the unique genetic profile of each case, showcasing the evolving landscape of personalized medicine in thalassemia management.

Integration of Non-Invasive Techniques:

  • Non-invasive prenatal testing (NIPT) continues to evolve as a valuable tool in thalassemia diagnosis.
  • Fetal medicine specialists leverage the advancements in NIPT, combining it with traditional diagnostic methods for a comprehensive assessment of thalassemia risk without invasive procedures.

Diagnostic Approaches in Fetal Medicine

  • Preconception Screening: Fetal medicine often begins its involvement with thalassemia through preconception screening, especially in populations with a high carrier rate. Identifying carriers helps couples make informed decisions about family planning.
  • Prenatal Diagnosis: For couples identified as carriers, prenatal diagnosis becomes crucial. Techniques such as chorionic villus sampling (CVS) or amniocentesis allow for the assessment of fetal DNA, enabling early detection of thalassemia.
  • Non-Invasive Prenatal Testing (NIPT): Advances in fetal medicine include non-invasive prenatal testing, which analyzes cell-free fetal DNA circulating in the mother’s blood. While not a primary diagnostic tool for thalassemia, NIPT can indicate a risk, prompting further diagnostic procedures.

Management and Treatment in Fetal Medicine

  • Early Intervention: Fetal medicine specialists collaborate with obstetricians to provide early intervention strategies. This may involve transfusions in utero for severe cases, optimizing fetal outcomes.
  • Cord Blood Transplantation: In cases where thalassemia is diagnosed early, fetal medicine opens avenues for cord blood transplantation, potentially curing the condition before birth.
  • Gene Therapy: Ongoing research in fetal medicine explores gene therapy as a potential treatment for thalassemia. CRISPR technology and other genetic editing tools offer promise in correcting or mitigating the genetic mutations responsible for thalassemia.

Genetic Counseling and Family Support

Fetal medicine specialists engage in comprehensive genetic counseling, ensuring families understand the implications of thalassemia and their reproductive options. This support extends beyond diagnosis, addressing emotional and ethical considerations associated with genetic conditions.

Thalassemia in fetal medicine requires a multidisciplinary approach, combining genetic expertise, prenatal diagnostics, and evolving treatment modalities. As research progresses, fetal medicine continues to play a pivotal role in navigating thalassemia, offering hope for affected families and contributing to the broader landscape of genetic medicine.

blog page Thalassemia

Ways Thalassemia Can Impact Pregnancy and Family Planning

Blood-related genetic problems are a complex issue that can affect one’s family planning. Thalassemia is a common blood transfused disease that passes on from the parent to the child. It is transmitted by mutated haemoglobin cells. In India, around 10000 to 15000 babies are born with this problem.

More About Thalassemia:

Thalassemia, being an inherited medical condition, affects an infant badly. The body suffers from genetic mutation, where it cannot produce enough haemoglobin. Haemoglobin is a protein structure in RBC responsible for carrying and supplying Oxygen to different body parts.

Symptoms of Thalassemia:

Conducting a thalassemia test of both parents is crucial before conceiving. The haemoglobin forming DNA of the thalassemia patients mutates in this problem. One can identify it through different symptoms, including:

  • Fatigue
  • Dark urine
  • Abnormal growth of the child
  • Yellow or pale skin
  • Deformities in facial structure

Causes of Thalassemia and its Testing:

The haemoglobin in the RBC is formed of two identical chains of proteins. These are identified as Alpha and Beta. Thalassemia is categorised into two parts. One can confirm on which the protein chain is damaged. Therefore, these are known as Alpha Thalassemia and Beta Thalassemia.

One can also classify thalassemia based on its severity. These are broadly classified into three parts:

  • Thalassemia Trait: In this case, one parent possesses an abnormal DNA haemoglobin molecule. The other one may have a normal genetic structure. In such cases, the child will carry the Thalassemia trait with mild anaemia.
  • Thalassemia Major: As the name suggests, this type of thalassemia is a major issue that needs immediate medical attention. The baby of a parent with two defective gene sets may suffer from this problem.
  • Thalassemia Intermedia: It is an intermediate thalassemia condition. Here one needs close health monitoring with periodic check-ups.

If someone thinks that thalassemia is a deterrent to family planning, they are wrong. One can conceive through these effective processes:

  • CVS Testing: It is a vital testing method involving collecting chorionic villi cells from the placenta.
  • Amniocentesis: In this test, the tester collects a small amount of fluid from the amniotic sac. The amniotic fluid surrounding the embryo can effectively indicate the signs of thalassemia.

IFM Fetal Medicine Unit Kolkata

Now that one knows all the details about thalassemia and its effects on family planning; it will be easier to make the right decisions. For better testing assistance, one should contact a reliable source like Institute of Fetal Medicine. We are a premier source in Kolkata for thalassemia tests. For more information, one can visit our website today.

blog page Thalassemia

All You Need To Know About Thalassemia During Pregnancy

Most expectant mothers with Thalassemia traits have very little knowledge about the condition during pregnancy and the tests they have to undertake after they have conceived a child. So, the first thing you have to do is get your partner screened if you have Thalassemia. It will help you determine whether there is a chance for the condition to pass onto your child.

What Do You Mean By Thalassemia? How Is It Caused?

It is a hereditary condition that prevents our body from producing adequate haemoglobin, responsible for carrying oxygen through our bloodstream.  Haemoglobin is a protein present in red blood cells and comprises four protein subunits. More than 9000 children are born with Beta Thalassemia every year, making it one of India’s most common single-gene disorders. If you don’t want your child to be the next, visit the Institute of Fetal Medicine for Thalassemia Test in Kolkata.

How To Test For Thalassemia During Pregnancy?

You and your partner can get screened for Thalassemia both before and after conceiving a baby. Two common tests are the High-Performance Liquid Chromatography and Hemoglobin electrophoresis test. In addition, the doctor will conduct a blood test known as Complete Blood Count to track the presence of the Thalassemia trait in one’s body, the number of red blood cells and haemoglobin concentration.

What Does The Test Result Indicate?

Did you and your partner undergo the test before your pregnancy, and the test result showed that both of you are a silent carrier of Thalassemia? There is a 50% chance that your baby will become a carrier, there is a 25% chance that both of you being Thalassemia carrier won’t impact him and a 25% chance that your child will get the inherited blood disorder.

Do You Have To Worry About Thalassemia During Pregnancy?

Thalassemia is harmful to the unborn child during pregnancy if you fail to detect it at the right time. Expectant mothers should visit the Institute of Fetal Medicine for antenatal checkups at fixed intervals so doctors can closely monitor their health. Some doctors consider pregnancy with Thalassemia as a high-risk pregnancy.

The expectant mother can develop anaemia during her pregnancy if she only carries the traits. Proper management is necessary to prevent the condition from becoming severe. Prenatal testing will be necessary if both the parents have the trait. The test is done before the mother crosses her 12th-week pregnancy and helps in determining whether the baby will be born with Thalassemia Major.

What Is Beta-Thalassemia Major?

It is a severe condition when the child inherits one faulty gene from each parent. The number of healthy red blood cells in their body might be less than required. It makes them incapable of supplying sufficient oxygen through their body and causes life-threatening anaemia.

Conduct a Thalassemia test at the right time and you can decide whether you want to continue with the pregnancy or not.